Source: Proactive Investors

GeneType: Genetic Technologies focuses on core business and revenue growth

Following a comprehensive operations review, Genetic Technologies Limited (ASX:GTG, NASDAQ:GENE, OTC:GNTLF) has implemented a strategic restructure which...

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
Simon Morriss's photo - CEO of GeneType

CEO

Simon Morriss

CEO Approval Rating

- -/100

Read more